Get access

Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells


Alon Lang, MD, Department of Gastroenterology, Chaim Sheba Medical Center Affiliated with Tel-Aviv University Tel-Hashomer 5261, Israel.
Tel: 972 3 5302679
Fax: 972 3 5303160


Abstract: Background/aims: Activated hepatic stellate cells (HSCs) have been implicated in hepatic fibrosis. Somatostatin (SOM) has an immunomodulatory role. The aim of this study was to assess the secretion of pro-inflammatory cytokines by HSCs and to determine the effect of SOM on the secretion of these mediators.

Methods: Activated rat HSCs were evaluated for their secretion of IL-1β, IL-8, and TNF-α using ELISA. RNA protection assay was used to determine cytokine mRNA levels. The expression of chemokine and cytokine mRNA and the secretion of these mediators were assessed following incubation with SOM or octreotide.

Results: HSCs spontaneously secreted IL-1β, IL-8, and TNF-α. This secretion was augmented following stimulation by IL-1β and TNF-α. SOM inhibited the spontaneous and TNF-α-induced secretion of IL-1β, IL-8, and TNF-α and suppressed the expression of IL-1β and TNF-α mRNA. Octreotide suppressed the secretion of IL-1β and IL-8.

Conclusions: These observations indicate that SOM exerts an inhibitory immunomodulatory effect on HSCs.

Get access to the full text of this article